π° Crinetics Pharma $CRNX rockets +99% β Vertex drops $10B to buy the biotech
Crinetics Pharmaceuticals is nearly doubling this morning after Vertex Pharmaceuticals announced a $10 billion deal to acquire the company β one of the biggest biotech buyouts of the year. CRNX shareholders are getting a massive premium payday while Vertex bets big on Crineticsβ pipeline. A reminder of how fast a single biotech holding can change your whole portfolio. Would you have had the conviction to hold CRNX into this news, or does this kind of payday just feel like luck? Not financial advice.
β‘ 43 buzzing
524 views
π 0 subscribed